Saw palmetto did not differ from placebo for benign prostatic hyperplasia in men: COMMENTARY

Wilt, Timothy J.
July 2006
ACP Journal Club;Jul/Aug2006, Vol. 145 Issue 1, p12
Academic Journal
The article presents information on a study related to herbal therapies. The study finds that enthusiasm for herbal therapies for lower urinary tract symptoms has been prompted by previous reviews concluding that various herbal therapies slightly improved urologic symptoms. The study findings suggest that saw palmetto maintains prostate health or prevents development of urinary symptoms or prostate cancer. According to the researchers, the literature on herbal extracts is limited by short study durations, variability in study designs and reporting of outcomes.


Related Articles

  • Muscarinic Receptors: Rationale for Overactive Bladder Treatment. Ruggieri, Michael R. // Urology Times;10/1/2006, Vol. 34 Issue 12, Special section p2 

    The article discusses the study which showed that overactive bladder is basically an imbalance between the afferent and efferent input into the bladder. Data collected for several years showed that both M2 and 3 receptors may be playing a role in the sensory and myogenic pathways in bladder...

  • Measuring Urgency End Points in the OAB Syndrome. Zinner, Norman R. // Urology Times;10/1/2006, Vol. 34 Issue 12, Special section p4 

    The article cites a study which found that while the Indevus Urgency Severity Scale is a valid urgency measurement scale for evaluation of clinical efficacy, the Overactive Bladder Symptom Composite Score (OABSCS) offers a single quantifiable value to the total number and severity of overactive...

  • Recurrent episodes of hematuria: A rare presentation of leiomyosarcoma of prostate. Talapatra, Kaustav; Nemade, Bhushan; Bhutani, Ritu; Kane, Shubhada; Bakshi, Ashish; Muckaden, Mary Ann; Laskar, Siddhartha // Journal of Cancer Research & Therapeutics;Oct-Dec2006, Vol. 2 Issue 4, p212 

    Leiomyosarcoma of the prostate is an extremely rare entity. Sarcomas account for about 1% of all malignant tumors and less than 5% of them arise from the genitourinary tract. Majority of patients present with urinary obstructive symptoms. The outcome is generally poor. Surgery with or without...

  • pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract. Langner, Cord; Hutterer, Georg; Chromecki, Thomas; Winkelmayer, Ingrid; Rehak, Peter; Zigeuner, Richard // Modern Pathology;Feb2006, Vol. 19 Issue 2, p272 

    Clinicopathologic features predictive of patient outcome in upper urinary tract urothelial carcinoma are not well defined. The aim of this study was to assess the role of pT classification, tumor grade, and vascular invasion in predicting metastasis-free survival. A total of 190 consecutive...

  • GOTTA GO RIGHT NOW. Karpa, Kelly Dowhower // Drug Topics;3/8/2004, Vol. 148 Issue 5, p60 

    Provides information about the urological disorders that plaque women and their existing drug treatments. Definition of the term overactive bladder (OAB); Significance of therapeutic advances to help women with OAB to become more comfortable in talking with doctors about the disease;...

  • Thermal Effects of Laparoscopic Saline-Enhanced Radiofrequency Cautery on Renal Parenchyma in a Porcine Model. Candace F. Granberg; Mitchell R. Humphreys; Erik Castle; Jeffery Slezak; Matthew T. Gettman; Paul E. Andrews // Journal of Endourology;Jan2008, Vol. 22 Issue 1, p139 

    Purpose Advances in the field of surgery have recently developed a number of devices and materials to improve surgical hemostasis. The effects of one such device, saline-cooled monopolar radiofrequency electrocautery, has been well scrutinized in splenic and hepatic applications. Despite the...

  • New Treatment for Overactive Bladder. Dmochowski, Roger R. // Urology Times;Aug2004 Supplement, Vol. 32, p10 

    The article focuses on new treatments for overactive bladder. The two newest therapies for overactive bladder (OAB) include trospium chloride, recently approved by the U.S. Food and Drug Administration and the investigational agents, darifenacin and solifenacin. With these therapies, like the...

  • References.  // Urology Times;Aug2004 Supplement, Vol. 32, p12 

    The article presents a list of papers related to overactive bladder. Some of them are — "The Standardisation of Terminology in Lower Urinary Tract Function: Report From the Standardisation Sub-Committee of the International Continence Society," by Abrams P. Cardozo; "Diagnosis and...

  • PROGRAM EVALUATION FORM.  // Urology Times;Aug2004 Supplement, Vol. 32, p14 

    The article presents a program evaluation form for the treatment of overactive bladder. August 31, 2005 is the last date to submit this form.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics